What is it about?
This article reviews how curcumin, the active compound in turmeric, can be turned into nanomedicines to better fight disease. Curcumin has long been known for its antioxidant and anti-inflammatory powers, but it is not well absorbed in the body. Nanotechnology solves this by packaging curcumin into nanoparticles, liposomes, micelles, and other carriers that make it more stable and effective. The review compiles evidence from 66 studies showing benefits across many conditions, including arthritis, atherosclerosis, Alzheimer’s, Parkinson’s, multiple sclerosis, inflammatory bowel disease, psoriasis, liver fibrosis, epilepsy, and even COVID-19.
Featured Image
Photo by NOAA on Unsplash
Why is it important?
Chronic inflammation drives some of today’s most serious diseases, yet current drugs often bring high costs and side effects. This review shows that nanomedicines can unlock curcumin’s full therapeutic potential, offering safer, more accessible options to support patients. It highlights how combining ancient natural remedies with cutting-edge nanotechnology may transform the way we manage inflammation-driven conditions.
Perspectives
What I find most exciting is the meeting point of tradition and innovation: a spice used for centuries is now reimagined through nanotechnology to tackle some of today’s most challenging diseases. To me, this research reflects the promise of science to bridge cultures, past and present knowledge, and open new frontiers in medicine.
Dr. Rosa Direito
Universidade de Lisboa
Read the Original
This page is a summary of: Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review, Pharmaceutics, January 2023, MDPI AG,
DOI: 10.3390/pharmaceutics15010229.
You can read the full text:
Contributors
The following have contributed to this page
